Address: C76, Balewadi, Pune, Maharashtra

Uveitis Treatment Market Outlook 2020: Global Opportunity and Demand Analysis, Market Forecast, 2019-2028

  • Home
  • Reports
  • Uveitis Treatment Market Outlook 2020: Global Opportunity and Demand Analysis, Market Forecast, 2019-2028
Uveitis Treatment Market Outlook 2020: Global Opportunity and Demand Analysis, Market Forecast, 2019-2028

Uveitis Treatment Market Outlook 2020: Global Opportunity and Demand Analysis, Market Forecast, 2019-2028

  • Published Date: 02 Apr 2021
  • Report ID: HLT 00175
  • Pages:167
  • Base Year: 2019
  • Format: PDF
  • Historical Data: 2016-2019

Uveitis is an eye inflammation affecting the middle layer of tissue in the eyewall. Some of the symptoms include pain, eye redness, and blurred vision. The condition can affect the lens, optic nerve, retina, and vitreous, creating reduced vision or blindness. Uveitis can be caused by an eye problem or due to other inflammatory diseases affecting other parts of the body. It can occur at all ages, and majorly affects people between 20-60 years old. The inflammation can be acute or chronic, and the severe form can reoccur.

Top Driver: Increasing Incidences of Uveitis and Introduction of New Treatment

The primary driver in the market is the increasing prevalence of uveitis and the complications concerning it. Also, rising investment in the research and development of new drugs and treatments and the emerging biologics is fueling the market growth. The introduction of a new treatment solution for uveitis, such as corticosteroids and anti-inflammatory drugs, are gaining traction in the market due to the promising results. Moreover, rapid approvals of drugs and new drug administration routes that enhance the efficacy of the drug are other factors proliferating the global uveitis treatment market.

On the other hand, the costly prices of medications and adverse effects of the medication, the lack of knowledge about eye disorders in developing countries, and the lack of health insurance are anticipated to hinder the market.

Corticosteroid Accounts for the Largest Market Share

Based on the treatment type, the market has been segmented into monoclonal antibodies, corticosteroids, antibiotics, and others. Among these, corticosteroids account for the largest market share owing to its good results—corticosteroid medicines aids in reducing inflammation. Various corticosteroid eye drops are approved by the Food and Drug Administration (FDA) as they are most commonly recommended by ophthalmologists. Based on the disease type, the market is segmented into intermediate uveitis, posterior uveitis, anterior uveitis, and pan uveitis. Based on the distribution channel, the market is segmented into retail, online, and hospital.

    

Rising Incidences and R & D Activities to Benefit North America Market

North America holds the largest market share owing to the rising incidence of non-infectious uveitis in the US. As many drugs are easily accessible in the US, thereby stimulating the country’s demand. This has encouraged increased R&D activities as well as increased healthcare expenditure. The rising geriatric population is also one of the major factors driving the market. Following North America, Asia Pacific is anticipated to create lucrative opportunities for the significant players.

Players to Focus on Uveitis treatment market

The market is anticipated to stay fragmented due to the increasing number of new entrants in the coming years. Few of the key companies operating in uveitis treatment market include Bausch & Lomb, Novartis AG, EyeGate, Santen Pharmaceutical Co., Ltd, EyePoint Pharmaceuticals, ALLERGAN, Alimera Sciences, Regeneron Pharmaceuticals, Wize Pharma Inc., Enzo Biochem Inc., and Alcon Inc.

Bausch Health Companies Inc.: In October 2019, Bausch Health Companies Inc. announced today that an affiliate of Bausch Health acquired an exclusive license for the commercialization and development of XIPERE™ (triamcinolone acetonide suprachoroidal injectable suspension) in the United States and Canada. XIPERE is a proprietary suspension of the corticosteroid triamcinolone acetonide formulated for suprachoroidal administration.

EyePoint Pharmaceutical:  Feb. 04, 2019, EyePoint Pharmaceuticals, Inc. commercially launched YUTIQTM in the United States. YUTIQ is for the treatment of chronic non-infectious uveitis affecting the posterior segment of the eye. Besides, the Company has also introduced EyePoint Assist, a program to ensure access to YUTIQ for eligible patients in need of financial assistance. 

By Treatment

  • Monoclonal antibodies
  • Corticosteroids
  • Antibiotics
  • Others

By Disease type

  • Intermediate uveitis
  • Posterior uveitis
  • Anterior uveitis

By Distribution

  • Retail
  • Hospital
  • Online

By Region

  • North America
  • Europe
  • Asia Pacific
  • SAMEA

Key Reasons to Purchase this Report

  1. It provides a technological development map over time to understand the growth rate of the industry.
  2. The report offers a dynamic method to various factors that drive or restrain the growth of the market.
  3. It renders definite analysis for changing competitive dynamics.
  4. It builds a seven-year estimate based on how the market is predicted to grow.

Chapter 1          Overview And Scope

1.1            Market Vision

1.1.1        Market Definition

1.1.2        Market Scope

1.2            Market Segmentation

Chapter 2          Our Research Practice

2.1            Our Research Methodology

2.2            Data Triangulation

2.3            Data Sources

2.4            Assumptions for the study

2.5            Approach Adopted

Chapter 3          Executive Summary

3.1            Market Snapshot

3.2            Regional Snapshot

3.3            Segment Summary

Chapter 4          Covid-19 Impact Analysis

4.1            Overview

4.2            Prevalence analysis

4.3            Key Factor Impact Analysis

Chapter 5          Global Sleep Apnea Devices Market Forces

5.1            What’s Driving the Market

5.2            Porter’s Five Forces Analysis

5.2.1        Power of Suppliers

5.2.2        Threats From New Entrants

5.2.3        Power of Buyer

5.2.4        Threat From Substitute Product

5.2.5        Degree of Competition

Chapter 6          Global Sleep Apnea Devices Market -Industry Snapshots

6.1            Overview

6.1.1        Global Sleep Apnea Devices Market Value, 2019 – 2028, (US$ Bn)

6.2            Market Overview

6.2.1        Drivers Analysis

6.2.2        Restraint/Challenges analysis

6.2.3        Opportunity Analysis

6.3            Supply Chain/Value Chain Analysis

6.4            Market SWOT Analysis

Chapter 7          Global Sleep Apnea Devices Market Analysis, by Diagnostic Devices

7.1            Overview

7.2            Key Findings for Sleep Apnea Devices Market- By Diagnostic Devices

7.2.1        Sleep Apnea Devices Market- Pulse oximeters

7.2.2        Sleep Apnea Devices Market- Actigraphy devices

7.2.3        Sleep Apnea Devices Market- Polysomnography Devices

Chapter 8          Global Sleep Apnea Devices Market Analysis, by Therapeutic Devices

8.1            Overview

8.2            Key Findings for Sleep Apnea Devices Market- By Therapeutic Devices

8.2.1        Sleep Apnea Devices Market- Oxygen Devices

8.2.2        Sleep Apnea Devices Market- Positive Airways Pressure Devices

8.2.3        Sleep Apnea Devices Market- Oral Appliances

8.2.4        Sleep Apnea Devices Market- Others

Chapter 9          Sleep Apnea Devices Market Analysis by Region

9.1            Key Findings for Sleep Apnea Devices Market- By region

9.2            Overview

9.2.1        Global Sleep Apnea Devices Market Analysis, By Diagnostic Devices, 2019 – 2028

9.2.2        Global Sleep Apnea Devices Market Analysis, By Therapeutic Devices, 2019 – 2028

9.3            Sleep Apnea Devices Market – North America

9.3.1        Overview

9.3.2        U.S.

9.3.3        Canada

9.3.4        Mexico

9.3.5        North America Market, By Diagnostic Devices

9.3.6        North America Market, By Therapeutic Devices

9.4            Sleep Apnea Devices Market – Europe

9.4.1        Overview

9.4.2        Germany

9.4.3        United Kingdom

9.4.4        France

9.4.5        Italy

9.4.6        Rest Of Europe

9.4.7        Europe Market, By Diagnostic Devices

9.4.8        Europe Market, By Therapeutic Devices

9.5            Sleep Apnea Devices Market – Asia Pacific

9.5.1        Overview

9.5.2        China

9.5.3        Japan

9.5.4        India

9.5.5        Rest of APAC

9.5.6        Asia Pacific Market, By Diagnostic Devices

9.5.7        Asia Pacific Market, By Therapeutic Devices

9.6            Sleep Apnea Devices Market – SAMEA

9.6.1        Overview

9.6.2        Middle East & Africa (MEA)

9.6.3        South America

9.6.4        Rest Of World

9.6.5        South America, Middle East and Africa Market, By Diagnostic Devices

9.6.6        South America, Middle East and Africa Market, By Therapeutic Devices

Chapter 10      Market Competition Analysis

10.1          Market Share/Positioning Analysis

10.1.1      Market Positioning of Key Vendors, 2019

10.1.2      Key Strategies Adopted by the Leading Players

10.1.3      Recent Developments

Chapter 11      Company Profiles- Snapshot

11.1          Curative Medical Inc

11.1.1      Business Fundamentals

11.1.2      Financial Snapshots

11.1.3      Product Portfolio

11.1.4      Recent Developments

11.2          Philips Respironics

11.3          ResMed

11.4          Fisher & Paykel Healthcare

11.5          Cadwell Laboratories

11.6          Invacare Corporation

*More than 10 Companies are profiled in this Research Report*

*Financials would be provided on a best efforts basis for private companies”

Chapter 12      Appendix

List of Figures

 

FIG. 1          Global Sleep Apnea Devices: Market Segmentation

FIG. 2          Global Sleep Apnea Devices Market: Research Methodology

FIG. 3          Top-Down and Bottom Up Approach

FIG. 4          Market Snapshot

FIG. 5          Porter’s Five Forces Analysis

FIG. 6          Global Sleep Apnea Devices Market Value, 2019 – 2028, (US$ Bn)

FIG. 7          Supply Chain/Value Chain Analysis

FIG. 8          Global Sleep Apnea Devices Market Value Contribution, By Diagnostic Devices, 2019 & 2026 (%)

FIG. 9          Global Sleep Apnea Devices Market Value Contribution, By Therapeutic Devices, 2019 & 2026 (%)

FIG. 10        Global Sleep Apnea Devices Market Value, 2019 – 2028, (US$ Bn)

FIG. 11        North America Sleep Apnea Devices Market Value, 2019 – 2028, (US$ Bn)

FIG. 12        Sleep Apnea Devices Market Segment 1 – North America

FIG. 13        Sleep Apnea Devices Market Segment 2 – North America

FIG. 14        Sleep Apnea Devices U.S. outlook, 2019 & 2026

FIG. 15        Sleep Apnea Devices Canada outlook, 2019 & 2026

FIG. 16        Sleep Apnea Devices Mexico outlook, 2019 & 2026

FIG. 17        Europe Sleep Apnea Devices Market Value, 2019 – 2028, (US$ Bn)

FIG. 18        Sleep Apnea Devices Market Segment 1 – Europe

FIG. 19        Sleep Apnea Devices Market Segment 2 – Europe

FIG. 20        Sleep Apnea Devices Germany outlook, 2019 & 2026

FIG. 21        Sleep Apnea Devices United Kingdom outlook, 2019 & 2026

FIG. 22        Sleep Apnea Devices France outlook, 2019 & 2026

FIG. 23        Sleep Apnea Devices Italy outlook, 2019 & 2026

FIG. 24        Sleep Apnea Devices Rest Of Europe outlook, 2019 & 2026

FIG. 25        Asia Pacific Sleep Apnea Devices Market Value, 2019 – 2028, (US$ Bn)

FIG. 26        Sleep Apnea Devices Market Segment 1 – Asia Pacific

FIG. 27        Sleep Apnea Devices Market Segment 2 – Asia Pacific

FIG. 28        Sleep Apnea Devices China outlook, 2019 & 2026

FIG. 29        Sleep Apnea Devices Japan outlook, 2019 & 2026

FIG. 30        Sleep Apnea Devices India outlook, 2019 & 2026

FIG. 31        Sleep Apnea Devices Rest of APAC outlook, 2019 & 2026

FIG. 32        SAMEA Sleep Apnea Devices Market Value, 2019 – 2028, (US$ Bn)

FIG. 33        Sleep Apnea Devices Market Segment 1 – SAMEA

FIG. 34        Sleep Apnea Devices Market Segment 2 – SAMEA

FIG. 35        Sleep Apnea Devices Middle East & Africa (MEA) outlook, 2019 & 2026

FIG. 36        Sleep Apnea Devices South America outlook, 2019 & 2026

FIG. 37        Sleep Apnea Devices Rest Of World outlook, 2019 & 2026

 

List of Tables

 

TABLE 1      Sleep Apnea Devices market by Diagnostic Devices 1, 2019 – 2028 (USD Million)

TABLE 2      Sleep Apnea Devices market by Diagnostic Devices 2, 2019 – 2028 (USD Million)

TABLE 3      Sleep Apnea Devices market by Diagnostic Devices 3, 2019 – 2028 (USD Million)

TABLE 4      Sleep Apnea Devices market by Therapeutic Devices 1, 2019 – 2028 (USD Million)

TABLE 5      Sleep Apnea Devices market by Therapeutic Devices 2, 2019 – 2028 (USD Million)

TABLE 6      Sleep Apnea Devices market by Therapeutic Devices 3, 2019 – 2028 (USD Million)

TABLE 7      Sleep Apnea Devices market by Therapeutic Devices 4, 2019 – 2028 (USD Million)

TABLE 8      Global Sleep Apnea Devices Market Value, By Diagnostic Devices, 2019 – 2028 (US$ Bn)

TABLE 9      Global Sleep Apnea Devices Market Value, By Therapeutic Devices, 2019 – 2028 (US$ Bn)

TABLE 10   Sleep Apnea Devices Market Analysis by North America (USD Million), 2019 – 2028

TABLE 11   U.S. Sleep Apnea Devices Market, 2019 – 2028 (USD Million)

TABLE 12   U.S. Sleep Apnea Devices Market, By Diagnostic Devices, 2019 – 2028 (USD Million)

TABLE 13   U.S. Sleep Apnea Devices Market, By Therapeutic Devices, 2019 – 2028 (USD Million)

TABLE 14   Canada Sleep Apnea Devices Market, 2019 – 2028 (USD Million)

TABLE 15   Canada Sleep Apnea Devices Market, By Diagnostic Devices, 2019 – 2028 (USD Million)

TABLE 16   Canada Sleep Apnea Devices Market, By Therapeutic Devices, 2019 – 2028 (USD Million)

TABLE 17   Mexico Sleep Apnea Devices Market, 2019 – 2028 (USD Million)

TABLE 18   Mexico Sleep Apnea Devices Market, By Diagnostic Devices, 2019 – 2028 (USD Million)

TABLE 19   Mexico Sleep Apnea Devices Market, By Therapeutic Devices, 2019 – 2028 (USD Million)

TABLE 20   Sleep Apnea Devices Market Analysis by Europe (USD Million), 2019 – 2028

TABLE 21   Germany Sleep Apnea Devices Market, 2019 – 2028 (USD Million)

TABLE 22   Germany Sleep Apnea Devices Market, By Diagnostic Devices, 2019 – 2028 (USD Million)

TABLE 23   Germany Sleep Apnea Devices Market, By Therapeutic Devices, 2019 – 2028 (USD Million)

TABLE 24   United Kingdom Sleep Apnea Devices Market, 2019 – 2028 (USD Million)

TABLE 25   United Kingdom Sleep Apnea Devices Market, By Diagnostic Devices, 2019 – 2028 (USD Million)

TABLE 26   United Kingdom Sleep Apnea Devices Market, By Therapeutic Devices, 2019 – 2028 (USD Million)

TABLE 27   France Sleep Apnea Devices Market, 2019 – 2028 (USD Million)

TABLE 28   France Sleep Apnea Devices Market, By Diagnostic Devices, 2019 – 2028 (USD Million)

TABLE 29   France Sleep Apnea Devices Market, By Therapeutic Devices, 2019 – 2028 (USD Million)

TABLE 30   Italy Sleep Apnea Devices Market, 2019 – 2028 (USD Million)

TABLE 31   Italy Sleep Apnea Devices Market, By Diagnostic Devices, 2019 – 2028 (USD Million)

TABLE 32   Italy Sleep Apnea Devices Market, By Therapeutic Devices, 2019 – 2028 (USD Million)

TABLE 33   Rest Of Europe Sleep Apnea Devices Market, 2019 – 2028 (USD Million)

TABLE 34   Rest Of Europe Sleep Apnea Devices Market, By Diagnostic Devices, 2019 – 2028 (USD Million)

TABLE 35   Rest Of Europe Sleep Apnea Devices Market, By Therapeutic Devices, 2019 – 2028 (USD Million)

TABLE 36   Sleep Apnea Devices Market Analysis by Asia Pacific (USD Million), 2019 – 2028

TABLE 37   China Sleep Apnea Devices Market, 2019 – 2028 (USD Million)

TABLE 38   China Sleep Apnea Devices Market, By Diagnostic Devices, 2019 – 2028 (USD Million)

TABLE 39   China Sleep Apnea Devices Market, By Therapeutic Devices, 2019 – 2028 (USD Million)

TABLE 40   Japan Sleep Apnea Devices Market, 2019 – 2028 (USD Million)

TABLE 41   Japan Sleep Apnea Devices Market, By Diagnostic Devices, 2019 – 2028 (USD Million)

TABLE 42   Japan Sleep Apnea Devices Market, By Therapeutic Devices, 2019 – 2028 (USD Million)

TABLE 43   India Sleep Apnea Devices Market, 2019 – 2028 (USD Million)

TABLE 44   India Sleep Apnea Devices Market, By Diagnostic Devices, 2019 – 2028 (USD Million)

TABLE 45   India Sleep Apnea Devices Market, By Therapeutic Devices, 2019 – 2028 (USD Million)

TABLE 46   Rest of APAC Sleep Apnea Devices Market, 2019 – 2028 (USD Million)

TABLE 47   Rest of APAC Sleep Apnea Devices Market, By Diagnostic Devices, 2019 – 2028 (USD Million)

TABLE 48   Rest of APAC Sleep Apnea Devices Market, By Therapeutic Devices, 2019 – 2028 (USD Million)

TABLE 49   Sleep Apnea Devices Market Analysis by SAMEA (USD Million), 2019 – 2028

TABLE 50   Middle East & Africa (MEA) Sleep Apnea Devices Market, 2019 – 2028 (USD Million)

TABLE 51   Middle East & Africa (MEA) Sleep Apnea Devices Market, By Diagnostic Devices, 2019 – 2028 (USD Million)

TABLE 52   Middle East & Africa (MEA) Sleep Apnea Devices Market, By Therapeutic Devices, 2019 – 2028 (USD Million)

TABLE 53   South America Sleep Apnea Devices Market, 2019 – 2028 (USD Million)

TABLE 54   South America Sleep Apnea Devices Market, By Diagnostic Devices, 2019 – 2028 (USD Million)

TABLE 55   South America Sleep Apnea Devices Market, By Therapeutic Devices, 2019 – 2028 (USD Million)

TABLE 56   Rest Of World Sleep Apnea Devices Market, 2019 – 2028 (USD Million)

TABLE 57   Rest Of World Sleep Apnea Devices Market, By Diagnostic Devices, 2019 – 2028 (USD Million)

TABLE 58   Rest Of World Sleep Apnea Devices Market, By Therapeutic Devices, 2019 – 2028 (USD Million)

Request for Sample

Please fill out the form to receive sample pages of the report